Trisomy 21 and Congenital Heart Disease: Impact on Health and Functional Outcomes From Birth Through Adolescence: A Scientific Statement From the American Heart Association
Journal of the American Heart Association · 2024-10 · 13 (19)
DOI: 10.1161/jaha.124.036214 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of the American Heart Association, 2024-10. Verfasst von Jennifer K Peterson und 10 weiteren Autor:innen. Hauptthemen laut MEDLINE: Down Syndrome, Heart Defects, Congenital, Quality of Life. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 165 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Due to improvements in recognition and management of their multisystem disease, the long‐term survival of infants, children, and adolescents with trisomy 21 and congenital heart disease now matches children with congenital heart disease and no genetic condition in many scenarios. Although this improved survival is a triumph, individuals with trisomy 21 and congenital heart disease have unique and complex care needs in the domains of physical, developmental, and psychosocial health, which affect functional status and quality of life. Pulmonary hypertension and single ventricle heart disease are 2 known cardiovascular conditions that reduce life expectancy in individuals with trisomy 21. Multisystem involvement with respiratory, endocrine, gastrointestinal, hematological, neurological, and sensory systems can interact with cardiovascular health concerns to amplify adverse effects. Neurodevelopmental, psychological, and functional challenges can also affect quality of life. A highly coordinated interdisciplinary care team model, or medical home, can help address these complex and interactive conditions from infancy through the transition to adult care settings. The purpose of this Scientific Statement is to identify ongoing cardiovascular and multisystem, developmental, and psychosocial health concerns for children with trisomy 21 and congenital heart disease from birth through adolescence and to provide a framework for monitoring and management to optimize quality of life and functional status.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Zitieren
APA
Peterson, J. K., Clarke, S., Gelb, B. D., Kasparian, N. A., Kazazian, V., Pieciak, K., Pike, N. A., Setty, S. P., Uveges, M. K., Rudd, N. A., & American Heart Association Pediatric Cardiovascular Nursing Committee of the Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Coun… (2024). Trisomy 21 and Congenital Heart Disease: Impact on Health and Functional Outcomes From Birth Through Adolescence: A Scientific Statement From the American Heart Association. Journal of the American Heart Association, 13(19). https://doi.org/10.1161/jaha.124.036214
Vancouver
Peterson JK, Clarke S, Gelb BD, Kasparian NA, Kazazian V, Pieciak K, et al. Trisomy 21 and Congenital Heart Disease: Impact on Health and Functional Outcomes From Birth Through Adolescence: A Scientific Statement From the American Heart Association. Journal of the American Heart Association. 2024;13(19). doi:10.1161/jaha.124.036214
BibTeX
@article{Peterson2024,
author = {Peterson, Jennifer K and Clarke, Shanelle and Gelb, Bruce D and Kasparian, Nadine A and Kazazian, Vanna and Pieciak, Karyn and Pike, Nancy A and Setty, Shaun P and Uveges, Melissa K and Rudd, Nancy A and American Heart Association Pediatric Cardiovascular Nursing Committee of the Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Coun…, American Heart Association Pediatric Cardiovascular Nursing Committee of the Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Coun…},
title = {Trisomy 21 and Congenital Heart Disease: Impact on Health and Functional Outcomes From Birth Through Adolescence: A Scientific Statement From the American Heart Association},
journal = {Journal of the American Heart Association},
year = {2024},
volume = {13},
number = {19},
doi = {10.1161/jaha.124.036214}
}
EUVIMED